Abeona Therapeutics Inc. (ABEO)

Abeona Therapeutics Statistics

Total Valuation

ABEO has a market cap or net worth of $247.78 million. The enterprise value is $161.19 million.

Market Cap	247.78M
Enterprise Value	161.19M

Important Dates

The last earnings date was Thursday, November 14, 2024, before market open.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

ABEO has 43.47 million shares outstanding. The number of shares has increased by 92.79% in one year.

Current Share Class	43.47M
Shares Outstanding	43.47M
Shares Change (YoY)	+92.79%
Shares Change (QoQ)	-6.14%
Owned by Insiders (%)	5.12%
Owned by Institutions (%)	42.60%
Float	28.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	63.10
PB Ratio	5.41
P/TBV Ratio	5.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.12, with a Debt / Equity ratio of 0.50.

Current Ratio	6.12
Quick Ratio	6.04
Debt / Equity	0.50
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-18.78

Financial Efficiency

Return on equity (ROE) is -209.50% and return on invested capital (ROIC) is -78.60%.

Return on Equity (ROE)	-209.50%
Return on Assets (ROA)	-40.68%
Return on Capital (ROIC)	-78.60%
Revenue Per Employee	n/a
Profits Per Employee	-$845,619
Employee Count	84
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +20.76% in the last 52 weeks. The beta is 1.44, so ABEO's price volatility has been higher than the market average.

Beta (5Y)	1.44
52-Week Price Change	+20.76%
50-Day Moving Average	6.16
200-Day Moving Average	5.66
Relative Strength Index (RSI)	37.95
Average Volume (20 Days)	229,161

Short Selling Information

The latest short interest is 2.58 million, so 5.93% of the outstanding shares have been sold short.

Short Interest	2.58M
Short Previous Month	2.63M
Short % of Shares Out	5.93%
Short % of Float	9.02%
Short Ratio (days to cover)	10.79

Income Statement

Revenue	n/a
Gross Profit	-31.40M
Operating Income	-60.75M
Pretax Income	-76.66M
Net Income	-71.03M
EBITDA	-58.79M
EBIT	-60.75M
Earnings Per Share (EPS)	-$2.01

Balance Sheet

The company has $109.70 million in cash and $23.11 million in debt, giving a net cash position of $86.59 million or $1.99 per share.

Cash & Cash Equivalents	109.70M
Total Debt	23.11M
Net Cash	86.59M
Net Cash Per Share	$1.99
Equity (Book Value)	45.77M
Book Value Per Share	1.05
Working Capital	94.24M

Cash Flow

In the last 12 months, operating cash flow was -$48.69 million and capital expenditures -$1.88 million, giving a free cash flow of -$50.57 million.

Operating Cash Flow	-48.69M
Capital Expenditures	-1.88M
Free Cash Flow	-50.57M
FCF Per Share	-$1.16

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ABEO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-92.79%
Shareholder Yield	-92.79%
Earnings Yield	-28.67%
FCF Yield	-20.41%

Analyst Forecast

The average price target for ABEO is $18.00, which is 215.79% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.00
Price Target Difference	215.79%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	113.80%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on July 5, 2022. It was a reverse split with a ratio of 0.04:1.

Last Split Date	Jul 5, 2022
Split Type	Reverse
Split Ratio	0.04:1

Scores

ABEO has an Altman Z-Score of -8.72 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.72
Piotroski F-Score	1